The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases

被引:0
|
作者
Nick R. Brown
Martin E. M. Noble
Jane A. Endicott
Louise N. Johnson
机构
[1] Laboratory of Molecular Biophysics and Oxford Centre for Molecular Sciences,Department of Biochemistry
[2] University of Oxford,undefined
来源
Nature Cell Biology | 1999年 / 1卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Progression through the eukaryotic cell cycle is driven by the orderly activation of cyclin-dependent kinases (CDKs). For activity, CDKs require association with a cyclin and phosphorylation by a separate protein kinase at a conserved threonine residue (T160 in CDK2). Here we present the structure of a complex consisting of phosphorylated CDK2 and cyclin A together with an optimal peptide substrate, HHASPRK. This structure provides an explanation for the specificity of CDK2 towards the proline that follows the phosphorylatable serine of the substrate peptide, and the requirement for the basic residue in the P+3 position of the substrate. We also present the structure of phosphorylated CDK2 plus cyclin A3 in complex with residues 658–668 from the CDK2 substrate p107. These residues include the RXL motif required to target p107 to cyclins. This structure explains the specificity of the RXL motif for cyclins.
引用
收藏
页码:438 / 443
页数:5
相关论文
共 50 条
  • [31] Functional Evolution of Cyclin-Dependent Kinases
    John H. Doonan
    Georgios Kitsios
    Molecular Biotechnology, 2009, 42 : 14 - 29
  • [32] CYCLIN-DEPENDENT KINASES - CLEAR AS CRYSTAL
    PINES, J
    CURRENT BIOLOGY, 1993, 3 (08) : 544 - 547
  • [33] Expression of cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors in oligodendrogliomas in humans
    Fiano, V
    Ghimenti, C
    Schiffer, D
    NEUROSCIENCE LETTERS, 2003, 347 (02) : 111 - 115
  • [34] Cyclins, Cyclin-Dependent Kinases, and Cyclin-Dependent Kinase Inhibitors in the Mouse Nervous System
    Alice Grison
    Suzana Atanasoski
    Molecular Neurobiology, 2020, 57 : 3206 - 3218
  • [35] Structural Basis for Interaction of Inhibitors with Cyclin-Dependent Kinase 2
    Canduri, Fernanda
    de Azevedo, Walter Filgueira, Jr.
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2005, 1 (01) : 53 - 64
  • [36] Structural basis for inhibition of cyclin-dependent kinase 9 by flavopiridol
    de Azevedo, WF
    Canduri, F
    da Silveira, NJF
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 293 (01) : 566 - 571
  • [37] Cyclins, Cyclin-Dependent Kinases, and Cyclin-Dependent Kinase Inhibitors in the Mouse Nervous System
    Grison, Alice
    Atanasoski, Suzana
    MOLECULAR NEUROBIOLOGY, 2020, 57 (07) : 3206 - 3218
  • [38] Roscovitine-derived, dual-specificity inhibitors of cyclin-dependent kinases and casein kinases 1
    Oumata, Nassima
    Bettayeb, Karima
    Ferandin, Yoan
    Demange, Luc
    Lopez-Giral, Angela
    Goddard, Marie-Lorene
    Myrianthopoulos, Vassilios
    Mikros, Emmanuel
    Flajolet, Marc
    Greengard, Paul
    Meijer, Laurent
    Galons, Herve
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (17) : 5229 - 5242
  • [39] Cyclin specificity in the phosphorylation of cyclin-dependent kinase substrates
    Loog, M
    Morgan, DO
    NATURE, 2005, 434 (7029) : 104 - 108
  • [40] Cyclin specificity in the phosphorylation of cyclin-dependent kinase substrates
    Mart Loog
    David O. Morgan
    Nature, 2005, 434 : 104 - 108